$760 Million is the total value of Simplify Asset Management Inc.'s 113 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| REPL | REPLIMUNE GROUP INC | $3,483,000 | +31.5% | 150,000 | 0.0% | 0.46% | +20.8% | |
| PHAT | PHATHOM PHARMACEUTICALS INC | $3,407,229 | +100.6% | 237,935 | 0.0% | 0.45% | +84.0% | |
| MDGL | MADRIGAL PHARMACEUTICALS INC | $3,301,914 | -4.6% | 14,294 | 0.0% | 0.44% | -12.5% | |
| APLT | APPLIED THERAPEUTICS INC | $3,049,755 | +57.8% | 2,382,621 | 0.0% | 0.40% | +45.1% | |
| AKRO | AKERO THERAPEUTICS INC | $2,790,988 | +22.0% | 59,777 | 0.0% | 0.37% | +11.9% | |
| MCRB | SERES THERAPEUTICS INC | $2,637,499 | -15.5% | 550,626 | 0.0% | 0.35% | -22.5% | |
| AN | AUTONATION INCput | $2,469,150 | +22.5% | 15,000 | 0.0% | 0.32% | +12.5% | |
| SAGE | SAGE THERAPEUTICS INC | $2,352,411 | +12.1% | 50,030 | 0.0% | 0.31% | +3.0% | |
| ANNX | ANNEXON INC | $2,300,260 | -8.6% | 653,483 | 0.0% | 0.30% | -16.1% | |
| MIRM | MIRUM PHARMACEUTICALS INC | $1,810,900 | +7.7% | 70,000 | 0.0% | 0.24% | -1.2% | |
| MARINUS PHARMACEUTICALS INC | $1,629,000 | +57.4% | 150,000 | 0.0% | 0.21% | +44.6% | ||
| RNA | AVIDITY BIOSCIENCES INC | $1,386,250 | -27.8% | 125,000 | 0.0% | 0.18% | -33.5% | |
| STOK | STOKE THERAPEUTICS INC | $1,305,321 | +27.6% | 122,796 | 0.0% | 0.17% | +17.0% | |
| ALLO | ALLOGENE THERAPEUTICS INC | $1,217,650 | +0.6% | 245,000 | 0.0% | 0.16% | -8.0% | |
| KDNY | CHINOOK THERAPEUTICS INC | $960,500 | +66.0% | 25,000 | 0.0% | 0.13% | +51.8% | |
| KURA | KURA ONCOLOGY INC | $846,400 | -13.5% | 80,000 | 0.0% | 0.11% | -20.7% | |
| XFOR | X4 PHARMACEUTICALS INC | $776,000 | +123.0% | 400,000 | 0.0% | 0.10% | +104.0% | |
| EIGR | EIGER BIOPHARMACEUTICALS INC | $774,156 | -21.5% | 1,099,653 | 0.0% | 0.10% | -28.2% | |
| STRO | SUTRO BIOPHARMA INC | $558,000 | +0.6% | 120,000 | 0.0% | 0.07% | -8.8% | |
| KYMR | KYMERA THERAPEUTICS INC | $242,131 | -22.4% | 10,532 | 0.0% | 0.03% | -28.9% | |
| ATAI | ATAI LIFE SCIENCES NV | $240,800 | -5.0% | 140,000 | 0.0% | 0.03% | -11.1% | |
| CLXPF | CYBIN INC | $189,000 | -1.8% | 500,000 | 0.0% | 0.02% | -10.7% | |
| ADAP | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $138,750 | -15.1% | 150,000 | 0.0% | 0.02% | -21.7% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ISHARES TR | 12 | Q3 2023 | 96.5% |
| TESLA INC | 12 | Q3 2023 | 0.2% |
| Invesco QQQ Trust Series 1 | 10 | Q1 2023 | 6.4% |
| TESLA INC | 10 | Q3 2023 | 9.1% |
| Crowdstrike Holdings Inc | 10 | Q1 2023 | 0.2% |
| SPDR S&P 500 ETF TRUST | 9 | Q2 2023 | 6.2% |
| CLOUDFLARE INC | 9 | Q1 2023 | 0.1% |
| Simplify Volatility Premium ETF | 8 | Q2 2023 | 2.4% |
| SIMPLIFY RISK PARITY TREASUR | 8 | Q3 2023 | 1.6% |
| CLOUDFLARE INC - CLASS A | 8 | Q1 2023 | 1.3% |
View Simplify Asset Management Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-13 |
| 13F-HR | 2024-02-12 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-10 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-11 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
View Simplify Asset Management Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.